# AKCEA THERAPEUTICS, INC.

AKCEA THERAPEUTICS, INC. is a company headquartered in Boston, MA, United States.

## Company overview

- **Legal name:** AKCEA THERAPEUTICS, INC.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Boston, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001662524

## About

AKCEA THERAPEUTICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001662524, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-03-02, it reported annual revenue of USD 488,543,000; net income of USD 40,772,000; total assets of USD 599,250,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $488.5M (USD 488,543,000)
- **Net income:** $40.8M (USD 40,772,000)
- **Total assets:** $599.3M (USD 599,250,000)
- **Cash and equivalents:** $306.9M (USD 306,866,000)
- **Operating cash flow:** $223.8M (USD 223,825,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $64.9M (USD 64,867,000)
- **Net income:** -$225.8M (USD -225,821,000)
- **Total assets:** $365.3M (USD 365,261,000)
- **Cash and equivalents:** $86.5M (USD 86,454,000)
- **Operating cash flow:** -$202.9M (USD -202,888,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $55.2M (USD 55,209,000)
- **Net income:** -$109.8M (USD -109,751,000)
- **Total assets:** $268.8M (USD 268,804,000)
- **Cash and equivalents:** $58.4M (USD 58,367,000)
- **Operating cash flow:** -$36.2M (USD -36,190,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2020-10-13 — period 2020-10-12 — 8-K
- Form 8-K — filed 2020-08-31 — period 2020-08-30 — 8-K
- Form 10-Q — filed 2020-08-05 — period 2020-06-30 — 10-Q
- Form 8-K — filed 2020-08-04 — period 2020-08-04 — 8-K
- Form 8-K — filed 2020-07-09 — period 2020-07-07 — 8-K
- Form 8-K — filed 2020-06-19 — period 2020-06-17 — 8-K
- Form 8-K — filed 2020-05-18 — period 2020-05-18 — 8-K
- Form 10-Q — filed 2020-05-06 — period 2020-03-31 — 10-Q
- Form 8-K — filed 2020-05-05 — period 2020-05-05 — 8-K
- Form 8-K — filed 2020-04-29 — period 2020-04-24 — 8-K
- Form 8-K — filed 2020-04-09 — period 2020-04-04 — 8-K
- Form 8-K — filed 2020-03-24 — period 2020-03-19 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/akcea-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology